Brief: Ryvu Therapeutics Signs EUR 4 Mln Financial Support Deal For 'Remark' Study
20/10/2023 06:40
Oct 20 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SIGNS FINANCIAL SUPPORT DEAL WITH GCP-SERVICE
INTERNATIONAL WEST
GMBH AND UWE PLATZBECKER
* DEAL FOR 'REMARK' CLINICAL STUDY
* EST. LEVEL OF FUNDING FROM RYVU AT ABOUT EUR 4 MILLION
Source text for Eikon: ID:nEM8V9y1ca
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project